These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2835850)

  • 1. Duration of circulating antibody and immunity following infection with equine influenza virus.
    Hannant D; Mumford JA; Jessett DM
    Vet Rec; 1988 Feb; 122(6):125-8. PubMed ID: 2835850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody isotype responses in the serum and respiratory tract to primary and secondary infections with equine influenza virus (H3N8).
    Hannant D; Jessett DM; O'Neill T; Mumford JA
    Vet Microbiol; 1989 Apr; 19(4):293-303. PubMed ID: 2546319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8).
    Mumford J; Wood JM; Scott AM; Folkers C; Schild GC
    J Hyg (Lond); 1983 Jun; 90(3):385-95. PubMed ID: 6306098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
    Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus.
    Mumford JA; Wood JM; Folkers C; Schild GC
    Epidemiol Infect; 1988 Jun; 100(3):501-10. PubMed ID: 2837409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.
    Nelson KM; Schram BR; McGregor MW; Sheoran AS; Olsen CW; Lunn DP
    Vaccine; 1998 Aug; 16(13):1306-13. PubMed ID: 9682395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8).
    Newton JR; Townsend HG; Wood JL; Sinclair R; Hannant D; Mumford JA
    Equine Vet J; 2000 Jan; 32(1):65-74. PubMed ID: 10661388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding.
    Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
    Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.
    Mumford JA; Wilson H; Hannant D; Jessett DM
    Epidemiol Infect; 1994 Apr; 112(2):421-37. PubMed ID: 8150017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
    Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
    Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene.
    Lunn DP; Soboll G; Schram BR; Quass J; McGregor MW; Drape RJ; Macklin MD; McCabe DE; Swain WF; Olsen CW
    Vaccine; 1999 May; 17(18):2245-58. PubMed ID: 10403592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
    Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
    Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses.
    Wattrang E; Jessett DM; Yates P; Fuxler L; Hannant D
    Viral Immunol; 2003; 16(1):57-67. PubMed ID: 12725689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines.
    Mumford JA; Jessett DM; Rollinson EA; Hannant D; Draper ME
    Vet Rec; 1994 Feb; 134(7):158-62. PubMed ID: 8160328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression.
    Lunn DP; Hussey S; Sebing R; Rushlow KE; Radecki SV; Whitaker-Dowling P; Youngner JS; Chambers TM; Holland RE; Horohov DW
    J Am Vet Med Assoc; 2001 Mar; 218(6):900-6. PubMed ID: 11294315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the duration and distribution of equine influenza virus subtype 2 (H3N8) antigens in experimentally infected ponies in vivo.
    Sutton GA; Viel L; Carman PS; Boag BL
    Can J Vet Res; 1997 Apr; 61(2):113-20. PubMed ID: 9114962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.